<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01778205</url>
  </required_header>
  <id_info>
    <org_study_id>IISPV_Murphy1</org_study_id>
    <secondary_id>SPAIN MICINN</secondary_id>
    <secondary_id>SPAIN ISCIII</secondary_id>
    <secondary_id>SPAIN URV</secondary_id>
    <secondary_id>SPAIN ISCIII</secondary_id>
    <nct_id>NCT01778205</nct_id>
  </id_info>
  <brief_title>The Reus-Tarragona Birth Cohort Study of Early Development and Ageing.</brief_title>
  <official_title>Phase 1 Study of the Effect of Maternal Nutritional Status on Placental Vascular Function, Fetal Growth and Intrauterine Growth Retardation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Investigacio Sanitaria Pere Virgili</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Italfarmaco</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CIBERobn</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut Investigacio Sanitaria Pere Virgili</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The recent fall in birth and death rates has led to demographic changes such as low fertility
      and high life expectancy . The WHO reports the median age of the European population to be
      the highest in the world and predicts that the proportion of over-60s in will increase from
      14% in 2010 to 25% in 2050. There is wide variability in the quality of health and well-being
      in the ageing population. Longevity with a good quality of life is a consequence of the
      combination of an individual's genes, nutrition, environment, lifestyle and medical
      interventions. There is increasing evidence that research into healthy ageing needs to start
      with early life data to capture all traits and exposures experienced by an individual
      throughout life. Epigenetic imprinting occurs both in utero and during early postnatal
      development. Maternal environmental exposures, including nutritional status, may have a
      permanent effect on the developing foetus by influencing epigenetic profiles and leading to
      life-long genome adaptation. Numerous reports show that restricted intra-uterine growth due
      to poor maternal nutrition during pregnancy increases risk in the offspring of developing
      mental disorders, metabolic syndrome, cardiovascular disease or stroke in later life. To
      understand the basic mechanisms and interactions through which the ageing phenotype develops,
      systems involved in key processes of early development must be considered as well as those
      crucial to health in older persons. The Reus and Tarragona Birth Cohort is a longitudinal
      study. In the first phase, blood is collected from pregnant women at &lt;12, 15, 24-27 and 34
      gestational weeks (GW) and at labor and from the cord. Detailed lifestyle, habits and
      supplement use data are collected at 20 and 32 gestational weeks and on nutritional habits at
      &lt;12GW and at birth. Placental vascular function is assessed at 20 and 32 GW by analysis of
      Doppler waveforms of the uterine arteries. Data on pregnancy evolution and outcome are also
      recorded. The first phase investigates the association between gene-environment (nutrient and
      lifestyle habits) interactions and fetal growth and pregnancy outcome. The second phase of
      the study follows up the children at 7.5 years of age. Growth, exercise and nutritional
      habits as well as environment and cognitive development are assessed. The aims are to
      investigate the association between gene-environment interactions associated with healthy
      development from early pregnancy until 7.5 years of age.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2005</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Birth weight</measure>
    <time_frame>At birth</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Doppler waveforms of uterine arteries</measure>
    <time_frame>20 gestational weeks</time_frame>
  </primary_outcome>
  <other_outcome>
    <measure>1-C metabolites</measure>
    <time_frame>&lt;12, 15, 24-27, 34 gestational weeks, at labor, in the cord</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Intrauterine growth retardation</measure>
    <time_frame>At birth</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Intrauterine Development</condition>
  <arm_group>
    <arm_group_label>Pregnant women</arm_group_label>
    <description>Pregnant women with confirmed viable fetus at first prenatal check-up at &lt;12 gestational weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
    <arm_group_label>Pregnant women</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma Serum Leukocytes Placenta
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women less than 12 weeks pregnant at their first pre-natal check up are recruited from the
        URV University Hospitals: Sant Joan (Reus) and Joan XXIII (Tarragona)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &lt;12 weeks pregnant at first prenatal check up

        Exclusion Criteria:

          -  Illnesses / interventions affecting nutritional status, major recent surgery in the
             previous 6 months, multiple pregnancies
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michelle M Murphy, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitat Rovira i Virgili</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pere Cavallé-Busquets, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitari Sant Joan de Reus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joan D Fernandez-Ballart, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Universitat Rovira i Virgili</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mónica Ballesteros, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital de Tarragona Joan XXIII</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michelle M Murphy, PhD</last_name>
    <phone>+34 977 758924</phone>
    <email>michelle.murphy@urv.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pere Cavallé-Busquets, MD, PhD</last_name>
    <phone>+34 977 337336</phone>
    <email>pecavalle@grupsagessa.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitari Sant Joan de Reus</name>
      <address>
        <city>Reus</city>
        <state>Tarragona</state>
        <zip>43201</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Pere Cavallé-Busquets, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joan Fernandez-Ballart, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pol Solé Navais, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michelle M Murphy, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gemma Ornosa, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julia Haro Barcelo, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Montserrat Ingles, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Montserrat Monclus, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marta Herrero Casado, BSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Tarragona Joan XXIII</name>
      <address>
        <city>Tarragona</city>
        <zip>43005</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Colomina JM, Cavallé-Busquets P, Fernàndez-Roig S, Solé-Navais P, Fernandez-Ballart JD, Ballesteros M, Ueland PM, Meyer K, Murphy MM. Maternal Folate Status and the BHMT c.716G&gt;A Polymorphism Affect the Betaine Dimethylglycine Pathway during Pregnancy. Nutrients. 2016 Oct 9;8(10). pii: E621.</citation>
    <PMID>27735840</PMID>
  </reference>
  <results_reference>
    <citation>Fernàndez-Roig S, Cavallé-Busquets P, Fernandez-Ballart JD, Ballesteros M, Berrocal-Zaragoza MI, Salat-Batlle J, Ueland PM, Murphy MM. Low folate status enhances pregnancy changes in plasma betaine and dimethylglycine concentrations and the association between betaine and homocysteine. Am J Clin Nutr. 2013 Jun;97(6):1252-9. doi: 10.3945/ajcn.112.054189. Epub 2013 Apr 17.</citation>
    <PMID>23595875</PMID>
  </results_reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2013</study_first_submitted>
  <study_first_submitted_qc>January 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2013</study_first_posted>
  <last_update_submitted>April 21, 2017</last_update_submitted>
  <last_update_submitted_qc>April 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut Investigacio Sanitaria Pere Virgili</investigator_affiliation>
    <investigator_full_name>Dr. Michelle Murphy</investigator_full_name>
    <investigator_title>Profesora agregat</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

